Jana Rolff
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Therapeutic targeting of ATR in alveolar rhabdomyosarcoma.
Journal: Nature communications
Published: December 20, 2020
Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid Tumors.
Journal: Translational oncology
Published: September 27, 2019
Prohibitin promotes de-differentiation and is a potential therapeutic target in neuroblastoma.
Journal: JCI insight
Published: April 19, 2019
Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progression.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 03, 2018
Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.
Journal: Genome medicine
Published: March 25, 2018
GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway.
Journal: Scientific reports
Published: January 04, 2018
Animal models for personalized treatment options.
Journal: International journal of clinical pharmacology and therapeutics
Published: July 12, 2017
Synergistic Antitumour Properties of viscumTT in Alveolar Rhabdomyosarcoma.
Journal: Journal of immunology research
Published: January 20, 2017
QSEA-modelling of genome-wide DNA methylation from sequencing enrichment experiments.
Journal: Nucleic acids research
Published: June 30, 2016
Last Updated: 09/26/2026